Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline
- PMID: 16315051
- DOI: 10.1007/s00345-005-0029-z
Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline
Abstract
This review draws the recent state of the art in metabolic diagnosis and metaphylaxis of stone disease. It is the basis for the consensus approval with the other medical societies and institutions in Germany involved in the guideline process of the new "Urolithiasis Guideline". The German Working Committee on Stone Disease reviewed critically the current literature in the field of urolithiasis-including the existing German and EAU-Guidelines as well as the Conference Book of the First International Consultation on Stone Disease. As far as possible the references were rated according to the EBM criteria. On this basis the expert group discussed all pathways and statements regarding the management of stone disease. The present review coincides with the consented guideline draft of the German Working Committee on Stone Disease. Occurrence of stone disease in the western world increases seriously. Modern lifestyle, dietary habits and overweight-problems of the affluent societies-emerge to be the important promoters of the "stone-boom" in the new millennium. This even affects children, whose stone prevalence is otherwise significantly less than that of adults. Criteria for the high risk group of stone formers were clearly defined. A diagnostic standard is formulated for the basic and the elaborate metabolic evaluation of a stone patient. Approximately 75% of all stone patients could anticipate stone recurrence with elementary reorientation of their lifestyle and dietary habits, summarized as general metaphylaxis. About 25% of the stone formers require additional pharmacological intervention to normalize their individual biochemical risk, precisely compiled for each stone type as specific metaphylaxis.
Comment in
-
Reliable data from diverse regions of the world exist to show that there has been a steady increase in the prevalence of urolithiasis.World J Urol. 2005 Nov;23(5):302-3. doi: 10.1007/s00345-005-0033-3. World J Urol. 2005. PMID: 16320059 No abstract available.
Similar articles
-
Rational evaluation of urinary stone disease.Urol Res. 2006 Apr;34(2):126-30. doi: 10.1007/s00240-005-0024-2. Epub 2006 Feb 1. Urol Res. 2006. PMID: 16450128 Review.
-
Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20. Eur Urol. 2015. PMID: 25454613
-
[Evidence-based pharmacological metaphylaxis of stone disease].Urologe A. 2006 Nov;45(11):1399-400, 1402-5. doi: 10.1007/s00120-006-1235-z. Urologe A. 2006. PMID: 17119896 Review. German.
-
[Metaphylaxis in the first occurrence of urolithiasis].Cas Lek Cesk. 2000 Dec;139 Suppl 1:16-8. Cas Lek Cesk. 2000. PMID: 11262895 Czech.
-
[What kind of stone prevention for whom? Risk-adjusted metaphylaxis following urinary stone disease].Urologe A. 2006 Nov;45(11):1387-8, 1390-1. doi: 10.1007/s00120-006-1224-2. Urologe A. 2006. PMID: 17082926 German.
Cited by
-
Urolithiasis--an interdisciplinary diagnostic, therapeutic and secondary preventive challenge.Dtsch Arztebl Int. 2015 Feb 6;112(6):83-91. doi: 10.3238/arztebl.2015.0083. Dtsch Arztebl Int. 2015. PMID: 25721435 Free PMC article. Review.
-
[Urinary calculi. Metabolism and diagnosis].Urologe A. 2006 Sep;45 Suppl 4:181-4. doi: 10.1007/s00120-006-1184-6. Urologe A. 2006. PMID: 16927082 Review. German. No abstract available.
-
[Urolithiasis in children--rational diagnosis, therapy, and metaphylaxis].Urologe A. 2008 May;47(5):545-50, 552-5. doi: 10.1007/s00120-008-1733-2. Urologe A. 2008. PMID: 18421432 Review. German.
-
[Qualitative and quantitative analysis of urolithiasis with the Rietveld method (x-ray diffraction)].Urologe A. 2008 Nov;47(11):1472-80. doi: 10.1007/s00120-008-1809-z. Urologe A. 2008. PMID: 18818896 German.
-
Anti-Transforming Growth Factor β IgG Elicits a Dual Effect on Calcium Oxalate Crystallization and Progressive Nephrocalcinosis-Related Chronic Kidney Disease.Front Immunol. 2018 Mar 29;9:619. doi: 10.3389/fimmu.2018.00619. eCollection 2018. Front Immunol. 2018. PMID: 29651290 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials